Login

Christoph Vilanek, CEO of Freenet, discusses corporate culture and leadership in a video with viewer comments. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek, CEO of Freenet

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Join us for an engaging podcast episode featuring Renaud de Viel Castel, COO and Head of Global Expansion at Rubicon Technologies, Inc.
00:10:00
First Helium: Pioneering Publicly Traded Helium Production
00:10:00
Assessing SEB's Economic Shifts and Outlook | Johan Torgeby, CEO, SEB.
00:10:00
"Quarterly Fund Recommendations for Q3 2024: Spotlight on B-SELECT from BBLAM"
00:00:00
Tissue Regenix Group "has the opportunity to become a global commercial organisation" - Danny Lee, CEO, Tissue Regenix Group
00:10:00
Cerberus Capital Management Honored as Community Champion at VOA-GNY Gala 2023
00:10:00
Tenable CEO Amit Yoran discusses recent spy balloon incidents and advancements in AI on CNBC.
00:10:00
Early stage companies with capital and expertise from active founders and operators|Ashley Mayer,Co-Founder and GP,Coalition Operators
00:10:00
Discussing Australian Foreign Policy with Sam Roggeveen from the Lowy Institute.|Sam Roggeveen,Professor,Lowy Institute
00:10:00
Exploring Gold in West Africa: Insights from Fluido's First One-to-One Conference in London
00:10:00
Karl-Emil Engström on IDUN Industrier AB’s Recent Acquisition and Future Strategy | Karl-Emil Engströml, CEO, IDUN Industrier AB.
00:10:00
Bruce Richards, Founder Chairman and CEO of Marathon Asset Management, shares insights on market conditions on 'Closing Bell'.

© 2017 - Neuhu+